中化裝備(600579.SH):天華院已在聚甲醛裝置後處理系統形成了一系列具有自主知識產權的工藝技術及關鍵設備
格隆匯5月26日丨中化裝備(600579.SH)在互動平台表示,聚甲醛後處理技術是聚甲醛裝置關鍵技術之一,天華院已在聚甲醛裝置後處理系統形成了一系列具有自主知識產權的工藝技術及關鍵設備。2024年3月初,由天華院承接的恒力石化(大連)新材料有限公司國內首套8萬噸/年聚甲醛裝置後處理系統一次性投料成功,系統運行穩定,聚甲醛產品質量對標國際先進水平。商務部對原產於美國、歐盟、中國台灣地區和日本的進口共聚聚甲醛徵收反傾銷税,對公司業務沒有直接影響,後續或將給公司聚甲醛裝置業務帶來新增量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.